Mannkind Corp., of Westlake Village, Calif., signed an exclusive marketing and distribution agreement with the AMSL Diabetes division of Australasian Medical & Scientific Ltd., of Chatswood, Australia, for the commercialization of Afrezza (insulin human) inhalation powder in Australia. The international partnership is Mannkind's third. Terms were not disclosed.